Tmothy J Church

Title: The Innovations of Tmothy J Church

Introduction

Tmothy J Church is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds that target the mu opioid receptor. His work is crucial in addressing various medical conditions associated with opioid receptor activity.

Latest Patents

Tmothy J Church holds a patent for "Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists." This invention provides novel 8-azabicyclo[3.2.1]octane compounds of formula (I), wherein R, R, R, and a are defined in the specification, or a pharmaceutically-acceptable salt thereof, that act as antagonists at the mu opioid receptor. The patent also includes pharmaceutical compositions comprising such compounds, methods of using these compounds to treat conditions associated with mu opioid receptor activity, and processes and intermediates useful for preparing such compounds. Tmothy has 1 patent to his name.

Career Highlights

Tmothy J Church is currently associated with Theravance, Inc., where he continues to innovate and contribute to the field of drug development. His expertise in pharmacology and medicinal chemistry has positioned him as a valuable asset in his organization.

Collaborations

Throughout his career, Tmothy has collaborated with several professionals, including Priscilla M Van Dyke and Daniel D Long. These collaborations have fostered a productive environment for research and development in the pharmaceutical industry.

Conclusion

Tmothy J Church's work exemplifies the impact of innovative thinking in the pharmaceutical sector. His contributions to the development of mu opioid receptor antagonists are paving the way for new treatment options.